BioNxt Solutions Inc.
BNXT
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 48.92% | 51.37% | 36.10% | 38.70% | 12.50% |
| Total Depreciation and Amortization | -43.33% | -24.18% | -16.91% | -10.09% | -48.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -23.44% |
| Total Other Non-Cash Items | -79.46% | -82.23% | -68.69% | -71.03% | -3.14% |
| Change in Net Operating Assets | 2,844.10% | 252.24% | 203.18% | 180.63% | 164.34% |
| Cash from Operations | 38.96% | 32.17% | 32.83% | 20.12% | 22.40% |
| Capital Expenditure | 28.90% | 31.26% | -3,423.81% | -4,873.33% | -550.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 330.85% | 323.17% | 1,866.67% | 2,533.33% | 97.43% |
| Total Debt Issued | -- | -- | -- | -- | 12.39% |
| Total Debt Repaid | 99.73% | 99.47% | 93.22% | 93.02% | -576.78% |
| Issuance of Common Stock | -47.36% | -42.77% | -61.54% | -7.24% | -53.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 43.99% | 40.07% | 55.41% | 5.02% | 57.48% |
| Cash from Financing | -36.17% | -35.90% | -61.15% | -0.06% | -69.82% |
| Foreign Exchange rate Adjustments | 33.33% | -70.97% | -145.83% | 112.20% | 122.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.37% | 84.92% | -5,154.89% | 118.52% | -230.63% |
